Stresshyperglykämie und intensivierte Insulintherapie in der Intensivmedizin - Freund oder Feind?[1]

Literatur

• 1 Corstjens A M, Horst I C, Zijlstra J G. et al . Hyperglycaemia in critically ill patients: marker or mediator of mortality?.  Critical Care. 2007;  10 216
• 2 Turina van der M, Fry D E, Polk H C. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects.  Crit Care Med. 2005;  33 1624-33
• 3 Vanhorebeek I, De Vos R, Mesotten D. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients.  Lancet. 2005;  365 53-59
• 4 Van den Berghe G. How does blood glucose control with insulin save lives in intensive care?.  J Clin Invest. 2004;  114 1187-1195
• 5 Van den Berghe G, Wouters P J, Bouillon R. et al . Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.  Crit Care Med. 2003;  31 359-66
• 6 DCCT Research Group . The effect of intensive treatment of Diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.  N Engl J Med. 1993;  329 977-986
• 7 Berghe van den G, Wouters P, Weekers F. et al . Intensive insulin therapy in the critically ill patients.  N Engl J Med. 2001;  345 1359-67
• 8 2008 http://www.emea.europa.eu/pdfs/human/ewp/ 471303en.pdf
• 9 Gandhi G Y, Nuttall G A, Abel M D. et al . Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial.  Ann Intern Med. 2007;  146 233-243
• 10 Gandhi G Y, Nuttall G A, Abel M D. et al . Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients.  Mayo Clin Proc. 2005;  80 (7) 862-866
• 11 Krinsley J S. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.  Mayo Clin Proc. 2003;  78 1471-1478
• 12 Van den Berghe G, Wilmer A, Hermans G. et al . Intensive insulin therapy in the medical ICU.  New England J Med. 2006;  354 449-461
• 13 Brunkhorst F M, Engel C, Bloos. et al . A Trial of Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis.  N Engl J Med. 2008;  358 (2) 125-139
• 14 Krinsley J S, Grover, A. Severe hypoglycemia in critically ill patients: Risk factors and outcomes.  Crit Care Med. 2007;  35 2262-2267
• 15 Berghe van den G, Wilmer A, Milants I. et al . Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm.  Diabetes. 2006;  55 3151-3159
• 16 Van Cromphaut S, Wilmer A, Van den Berghe G. .  New Engl J Med. 2007;  356 1180-1181 (letter)
• 17 Ellger B, Westphal M, Stubbe H D. et al . Blutzuckerkontrolle bei Sepsis Patienten mit Sepsis und septischem Schock - Freund oder Feind?.  Anaesthesist. 2008;  57 43-48
• 18 Brunkhorst F M, Reinhart K. Intensive insulin therapy in the ICU: benefit versus harm?.  Intensive Care Med. 2007;  33 (7) 1302 (letter)
• 19 Treggiari M M, Karir, Yanez. et al . Intensive insulin therapy and mortality in critically ill patients.  Critical Care. 2008;  12 R29 DOI: 10.1186 /cc6807
• 20 Kagansky N, Levy S, Rimon E. et al . Hypoglycemia as a predictor of mortality in hospitalized elderly patients.  Arch Intern Med. 2003;  163 1825-1829
• 21 2008 http://content.nejm.org/cgi/content/full/ 354 / 5 / 449 /DC1
• 22 Moeniralam H, Spronk P, Graat M. et al . .  Critical Care. 2005;  9 P388 (abstract)
• 23 Mackenzie I, Ingle S, Zaidi S. et al . .  Intensive Care Med. 2005;  31 1136 (abstract)
• 24 Cryer P E. Hypoglycemia, functional brain failure and brain death.  J Clin Invest. 2008;  117 868-870
• 25 Bhatia A, Cadman C, Mackenzie I. Hypoglycemia and Cardiac Arrest in a Critically Ill Patient on Strict Glycemic Control.  Anesth Analg. 2006;  103 787-788
• 26 Sinha S, Jayaram R, Hargreaves C G. Fatal neuroglycopaenia after accidental use of a glucose 5 % solution in a peripheral arterial cannula flush system.  Anaesthesia. 2007;  62 615-620
• 27 Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control.  American Journal of Critical Care. 2006;  15 370-377
• 28 Berghe van den G, Wouters P J, Kesteloot K. et al . Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients - cost savings compared with conventional insulin therapy.  Crit Care Med. 2006;  34 612-616
• 29 Krinsley J S, Jones R L. Cost analysis of intensive glycemic control in critically ill adult patients.  Chest. 2006;  129 644-650
• 30 Mackenzie I. et al . Hypoglyaecemia - so what?.  Intensive Care Med. 2006;  32 620-621 (letter)
• 31 Sakel M. Schizophreniebehandlung mittels Insulin-Hypoglykämie sowie hypoglykämischer Schocks.  Wiener Med Wschr. 1934;  45 1211-1214
• 32 Ebaugh F G. Annals of Internal Medicine. 1943: 294
• 33 ACCORD News Conference press kit,. 2008 http://www.nhlbi.nih.gov/health/prof/heart/other/accord/
• 34 Brunkhorst F M, Wahl H G. Blood glucose measurements in the critically ill: more than just a blood draw.  Crit Care. 2006;  10 (6) 178
• 35 Dungan K, Chapman J, Braithwaite S S. et al . Glucose measurement: confounding issues in setting targets for inpatient management.  Diabetes Care. 2007;  30 2) 403-409, Review
• 36 Egi M, Bellomo R, Stachowski E. et al . Variability of blood glucose concentration and short-term mortality in critically ill patients.  Anesthesiology. 2006;  105 244-252
• 37 Hovorka R. Continuous glucose monitoring and closed-loop systems.  Diabet Med. 2006;  23 1-12
• 38 Devos P, Preiser J C, Melot C. On behalf of the Glucontrol steering committee. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study.  Intensive Care Med. 2007;  33 S189
• 39 Target ranges for glycaemic control in intensive care unit (ICU) patients. 2008 http://controlled-trials.com/ isrctn/trial/ISRCTN04968275 / 0 / 04 968 275.html
• 40 Treggiari M M, Karir, Yanez. et al . Intensive insulin therapy and mortality in critically ill patients.  Critical Care. 2008;  12 R29 , 10.1186 /cc6807

1 Mit Unterstützung des Kompetenznetzwerkes Sepsis (SepNet); unterstützt durch das Bundesministerium für Bildung und Forschung (BMBF), Förderkennzeichen: 01KI 0106.